iRhythm raised 2026 revenue outlook to $890M-$895M and plans Zio MCT FDA filing in 2027.
Why it matters
iRhythm raised 2026 revenue outlook to $890M-$895M and plans Zio MCT FDA filing in 2027. — impact context not separately stored; see What changed.